Jay Shah ponders whether CDMO deals will revive next year to define pharma M&A.

Marion Jeng, associate at investment bank DAI Magister, identifies the femtech sectors healthcare investors should prioritise.

PR firm The PHA Group's Rob Scott-Collins describes how businesses can thrive in a prevention first world